Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Melanoma 13Lymphoma 11Lymphoma, Follicular 10Breast Neoplasms 10Multiple Myeloma 9Prostatic Neoplasms 8Neoplasms, Plasma Cell 8Leukemia, Myeloid, Acute 7Colonic Neoplasms 7Pancreatic Neoplasms 6Colorectal Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 5Lymphoma, Non-Hodgkin 5Leukemia 5Kidney Neoplasms 5Small Cell Lung Carcinoma 4Rectal Neoplasms 4Ovarian Neoplasms 4Neoplasms 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Lung Neoplasms 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4HIV Infections 4Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 4Acquired Immunodeficiency Syndrome 4Testicular Neoplasms 3

Interventions

Paclitaxel 3Cisplatin 2tofacitinib 1sodium thiosulfate 1sargramostim 1fludarabine 1aldesleukin 1Vaccines 1TKM-080301 1Surgical Procedures, Operative 1SS1(dsFv)PE38 1Positron Emission Tomography Computed Tomography 1Mitomycin 1Magnetic Resonance Imaging 1LMB-100 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fluorouracil 1Electrocardiography 1Cyclophosphamide 1Carboplatin 1Capecitabine 1Bevacizumab 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Adenocarcinoma × sargramostim × Clear all
NCT00088413 2019-04-16

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
51 enrolled 20 charts
BreastGastrointestinalGynecologic

Adenocarcinoma, Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡